Journals / 7tepe Klinik / 2019 / Cilt: 15 - Sayı: 1

Use of blood and blood products in the management of temporomandibular joint (TMJ) disorders: A systematic review

Temporomandibular eklem (TME) hastalıklarında kan ve kan ürünlerinin kullanımı: Sistematik derleme

Pages
97–102
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this systematic review, we aim to analyze the studies evaluating the effects of blood and blood products in the treatment of TMJ disorders.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Temporomandibular joint (TMJ) disorders are classified as extracapsular and intrcapsular originated.
📊
Key Findings & Data:In this classification, myofascial pain, internal derangement, degenerative joint diseases, and neoplasias can be included.
💡
Conclusion & Impact:In this systematic review, we aim to analyze the studies evaluating the effects of blood and blood products in the treatment of TMJ disorders.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Temporomandibular joint (TMJ) disorders are classified as extracapsular and intrcapsular originated. In this classification, myofascial pain, internal derangement, degenerative joint diseases, and neoplasias can be included. In the etiology of these disorders, trauma, infection, osteoarthritis, immunologic and metabolic diseases as well as pathological entities play role. In the management of TMJ disorders, conservative methods are commonly performed whereas surgical treatment is less preferred. In recent years, the use of patient’s blood and blood products are commonly used in regenerative therapy, and positive results are reported in the healing of both soft and hard tissues. In this systematic review, we aim to analyze the studies evaluating the effects of blood and blood products in the treatment of TMJ disorders.

Özet

Temporomandibular eklem (TME) hastalıkları; ekstrakapsüler ve intrakapsüler orijinli olarak sınıflandırılmaktadır. Bu sınıflandırma içinde, myofasiyal ağrı, iç düzensizlikler, dejeneratif hastalıklar ve neoplaziler dahil edilebilir. Bu hastalıkların etiyolojisinde travma, enfeksiyon, osteoartrit, immünolojik ve metabolik hastalıklar ile patolojik oluşumlar rol oynamaktadır. TME hastalıklarının tedavisinde konservatif yöntemler daha sıklıkla uygulanmakta olup cerrahi tedavi daha az tercih edilmektedir. Son yıllarda rejeneratif tedavide hastadan elde edilen kan ve kan ürünlerinin kullanımı yaygınlaşmakta, hem yumuşak doku hem kemik iyileşmesinde olumlu sonuçlar bildirilmektedir. Bu sistematik derlemede; TME hastalıklarının tedavisinde kan ve kan ürünlerinin etkinliğine yönelik yapılan araştırmaların analizi amaçlanmaktadır.

🔖

Cite This Article

SÜZEN, M., GÜRLER, G., DELİLBAŞI, Ç. (2019). Use of blood and blood products in the management of temporomandibular joint (TMJ) disorders: A systematic review. 7tepe Klinik, Cilt: 15 - Sayı: 1, 97–102. https://ajindex.com/articles/146196

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Okeson JP, de Leeuw R. Differential diagnosis of temporomandibular disorders and other orofacial pain disorders. Dent Clin North Am 2011;55(1):105-20.
  2. Gencer ZK, Ozkiris M, Okur A, Korkmaz M, Saydam L. A comparative study on the impact of intra-articular injections of hyaluronic acid, tenoxicam and betametazon on the relief of temporomandibular joint disorder complaints. J Craniomaxillofac Surg 2014;42(7):1117-21. Hegab AF. Treatment of chronic recurrent dislocation of the temporomandibular joint with injection of autologous blood alone, intermaxillary fixation alone, or both together: a prospective, randomised, controlled clinical trial. Br J Oral Maxillofac Surg 2013;51(8):813-7.
  3. Liu F, Steinkeler A. Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am 2013;57(3):465-79.
  4. Comert Kilic S, Gungormus M, Sumbullu MA. Is Arthrocentesis Plus Platelet-Rich Plasma Superior to Arthrocentesis Alone in the Treatment of Temporomandibular Joint Osteoarthritis? A Randomized Clinical Trial. J Oral Maxillofac Surg 2015;73(8):1473-83.
  5. Comert Kilic S, Gungormus M. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint osteoarthritis: a randomized clinical trial. Int J Oral Maxillofac Surg 2016;45(12):1538-44.
  6. Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-Rich Plasma Injection as an Effective Treatment for Temporomandibular Joint Osteoarthritis. J Oral Maxillofac Surg 2015;73(9):1706-13.
  7. Hanci M, Karamese M, Tosun Z, et al. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. J Craniomaxillofac Surg 2015;43(1):162-6.
  8. Kutuk N, Bas B, Soylu E, et al. Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint. J Oral Maxillofac Surg 2014;72(2):277- 84. Mihaylova Z, Mitev V, Stanimirov P, et al. Use of platelet concentrates in oral and maxillofacial surgery: an overview. Acta Odontol Scand 2017;75(1):1-11.
  9. Kraeutler MJ, Garabekyan T, Mei-Dan O. The use of platelet-rich plasma to augment conservative and surgi-cal treatment of hip and pelvic disorders. Muscles Ligaments Tendons J 2016;6(3):410-19.
  10. Pihut M, Szuta M, Ferendiuk E, Zenczak-Wieckiewicz D. Evaluation of pain regression in patients with temporomandibular dysfunction treated by intra-articular platelet-rich plasma injections: a preliminary report. Biomed Res Int 2014;2014:132